ZEPP

ZEPP EBITDA Growth

33.53%TTM

Period ending:

ZEPP TTM EBITDA YoY %%
ZEPP TTM EBITDA YoY %569.88%-1474.89%
2018-03-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

ZEPP ebitda growth history

Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 34 observations from Mar 31, 2018 to Jun 30, 2026.

Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
33.5265%
49.9782%
42.8823%
-26.0894%
-146.1678%
-320.1175%
-1,277.0068%
-545.7237%
-247.1027%
-83.4019%
42.9187%
-11.0455%
-163.1318%
-464.1488%
-301.7606%
-187.5625%
-142.2298%
-50.7095%
-39.8591%
-28.3242%
-44.5697%
-64.5517%
-58.2292%
-34.8838%
7.0455%
22.01%
59.6796%
63.028%
71.7842%
114.2813%
103.4244%
107.7199%
156.3884%
372.0011%

Compare ebitda growth

All ZEPP financial metrics · ZEPP stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.